Literature DB >> 2878935

Evidence for thyrotropin (TSH)-blocking activity in goitrous Hashimoto's thyroiditis with assays measuring inhibition of TSH receptor binding and TSH-stimulated thyroid adenosine 3',5'-monophosphate responses/cell growth by immunoglobulins.

N Takasu, T Yamada, M Katakura, K Yamauchi, Y Shimizu, Y Ishizuki.   

Abstract

There are two forms of autoimmune thyroiditis that may cause hypothyroidism: autoimmune atrophic thyroiditis (primary idiopathic hypothyroidism or primary myxedema) and autoimmune goitrous thyroiditis (Hashimoto's disease). Patients with the former have impalpable thyroid glands, and those with the latter have goiters. We studied TSH binding inhibitory immunoglobulins (TBII), TSH-stimulated cAMP response inhibitory immunoglobulins (TSII), and TSH-stimulated cell growth inhibitory immunoglobulins (TGII) in 42 patients with the former (group 1) and 115 patients with the latter (group 2). Porcine thyroid cells in primary culture and rat thyroid cells in continuous culture (FRTL-5 cells) were used to study TSII and TGII activities, respectively; TSII was expressed as percent inhibition of 0.1 mU/ml TSH-stimulated cAMP response by the patient's immunoglobulin (IgG; 1 mg/ml) during 2-h incubation, and TGII was expressed as percent inhibition of 10 mU/ml TSH-stimulated [14C]thymidine incorporation by the patient's IgG (1 mg/ml) during 24-h incubation. The new findings in this report are: some patients in both groups had TBII, TSII, and/or TGII; the frequency of the presence of TBII, TSII, and TGII in the patients with autoimmune atrophic thyroiditis was higher than that in the patients with autoimmune goitrous thyroiditis, and TSII and TGII were significantly associated with autoimmune atrophic thyroiditis; no correlation was found between goiter size and TBII, TSII, or TGII activity; and there were good correlations between TBII, TSII, and TGII activities. We also found that TSH-stimulated thymidine incorporation was through cAMP production and that the inhibitory IgGs inhibited TSH-stimulated thymidine incorporation by decreasing cAMP production in FRTL-5 cells, but not in porcine or human thyroid cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2878935     DOI: 10.1210/jcem-64-2-239

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  Analysis of risk factors for the development of type 2 diabetes mellitus complicated with Hashimoto's thyroiditis.

Authors:  Meng Han; Haoneng Wu; Weiming Yang; Juanjuan Chen
Journal:  BMC Endocr Disord       Date:  2022-07-08       Impact factor: 3.263

2.  Comparison of atrophic and goitrous auto-immune thyroiditis in children: clinical, laboratory and TSH-receptor antibody studies.

Authors:  N Matsuura; J Konishi; K Yuri; S Harada; K Fujieda; Y Nohara; Y Mikami; K Kasagi; Y Iida; A Hosoda
Journal:  Eur J Pediatr       Date:  1990-05       Impact factor: 3.183

3.  Detection of antibodies blocking thyrotropin effect using Chinese hamster ovary cells transfected with the cloned human TSH receptor.

Authors:  L Chiovato; P Vitti; G Bendinelli; F Santini; E Fiore; A Capaccioli; M Tonacchera; C Mammoli; M Ludgate; A Pinchera
Journal:  J Endocrinol Invest       Date:  1994-11       Impact factor: 4.256

4.  Development of autoimmune thyroid dysfunction after bilateral adrenalectomy in a patient with Carney's complex and after removal of ACTH-producing pituitary adenoma in a patient with Cushing's disease.

Authors:  N Takasu; N Ohara; T Yamada; I Komiya
Journal:  J Endocrinol Invest       Date:  1993-10       Impact factor: 4.256

5.  Insulin and insulin-like growth factor (IGF I) modulate the effects of bTSH on 3H-thymidine incorporation in human thyroid cells in primary culture.

Authors:  R Hoermann; B Saller; K Mann
Journal:  Klin Wochenschr       Date:  1989-10-02

6.  Antibody that blocks stimulation of cortisol secretion by adrenocorticotrophic hormone in Addison's disease.

Authors:  P Kendall-Taylor; A Lambert; R Mitchell; W R Robertson
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-28

7.  Thyroid disorders in Chinese patients with systemic lupus erythematosus.

Authors:  R T Tsai; T C Chang; C R Wang; C Y Chuang; C Y Chen
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

8.  Investigation of TSH receptor blocking antibodies in childhood-onset atrophic autoimmune thyroiditis.

Authors:  Keisuke Nagasaki; Akie Nakamura; Takeru Yamauchi; Hotaka Kamasaki; Yosuke Hara; Junko Kanno; Satomi Koyama; Yoshiaki Ohtsu; Ikuko Takahashi; Shigeru Suzuki; Kenichi Kashimada; Toshihiro Tajima
Journal:  Clin Pediatr Endocrinol       Date:  2021-04-03

9.  Changes of TSH-Stimulation Blocking Antibody (TSBAb) and Thyroid Stimulating Antibody (TSAb) Over 10 Years in 34 TSBAb-Positive Patients with Hypothyroidism and in 98 TSAb-Positive Graves' Patients with Hyperthyroidism: Reevaluation of TSBAb and TSAb in TSH-Receptor-Antibody (TRAb)-Positive Patients.

Authors:  Nobuyuki Takasu; Mina Matsushita
Journal:  J Thyroid Res       Date:  2012-05-10

Review 10.  Thyrotropin Receptor Blocking Antibodies.

Authors:  Tanja Diana; Paul D Olivo; George J Kahaly
Journal:  Horm Metab Res       Date:  2018-10-04       Impact factor: 2.936

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.